Muhamed Baljevic, MD, associate professor of Medicine, is the chair of Case-Based Insights on Hematologic Malignancies, a conference occurring Saturday, May 3, at The Westin Nashville that will feature several other Vanderbilt professors as speakers.
The event is a CME/ACPE-accredited conference that will be from 9 a.m. to 5 p.m. Speakers will address treatment updates and how their implications for standards of care for patients with both benign and malignant hematologic disorders. Topics will include multiple myeloma, lymphomas, acute leukemias, and cellular and T-cell receptor therapies. The registration cost is $150. For more information, visit Case-Based Insights on Hematologic Malignancies | Premier Hematology Oncology Conferences.
The target audience for the conference, which is a Binaytara event, is oncology researchers and clinicians. Binaytara is a nonprofit focused on oncology/hematology education and global oncology programs.
Vanderbilt clinicians on the conference agenda include Eden Biltibo, MD, Andrew Jallouk, MD, PhD, Katheryn Kennedy, APP, Ashwin, Kishtagari, MD, Sanja Mohan, MD, David Morgan, MD, Vivek Patel, MD, Sarah Profitt, PharmD, Kian Rahbari, MD, Michael Savona, MD, Salyka Sengsayadeth, MD, Megan Wanca, APP, Jarrod Smith, MD, Shakthi Bhaskar, MD, Adetola Kassim, MD, MS, and Augusto Dulanto Chiang.
